CAS 108-62-3

2,4,6,8-tetramethyl-1,3,5,7-tetraoxocane

Codes: BELOH-019

Application context (from source-drug indications)

Non-small cell lung cancerBelotecan HydrochlorideOvarian cancerBelotecan HydrochlorideSolid tumourBelotecan Hydrochloride

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Belotecan Hydrochloride	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Belotecan HydrochlorideOptimised routesteps: 2total yield: /

(S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione→(S)-4-ethyl-4-hydroxy-11-methyl-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione→2,4,6,8-tetramethyl-1,3,5,7-tetraoxocane→1,3,5-trioxane

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.